Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $57.25 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 06/12/2019 09:32:17 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $N/A | $57.25 | $N/A | $N/A | 0 | 06-12-2019 |
$ | $N/A | $57.25 | $N/A | $N/A | 0 | 06-11-2019 |
$ | $58.10 | $57.25 | $58.88 | $57.11 | 9,399,975 | 06-10-2019 |
$ | $56.34 | $58.08 | $58.14 | $56.34 | 6,085,826 | 06-07-2019 |
$ | $56.20 | $56.10 | $56.98 | $55.85 | 22,108,643 | 06-06-2019 |
$ | $57.35 | $56.51 | $57.50 | $56.39 | 1,635,146 | 06-05-2019 |
$ | $57.50 | $57.20 | $58.48 | $56.26 | 9,494,455 | 06-04-2019 |
$ | $57.84 | $57.65 | $58.17 | $57.02 | 2,127,805 | 06-03-2019 |
$ | $57.63 | $58.35 | $58.44 | $57.53 | 837,625 | 05-31-2019 |
$ | $56.50 | $56.35 | $56.72 | $55.93 | 286,156 | 05-30-2019 |
$ | $56.90 | $56.54 | $56.90 | $56.23 | 316,980 | 05-29-2019 |
$ | $57.40 | $57.10 | $57.42 | $57.05 | 448,986 | 05-28-2019 |
$ | $57.26 | $57.40 | $57.5823 | $56.8931 | 163,124 | 05-27-2019 |
$ | $57.26 | $57.40 | $57.5823 | $56.8931 | 163,124 | 05-24-2019 |
$ | $57.33 | $57.25 | $57.49 | $56.92 | 323,062 | 05-23-2019 |
$ | $58.00 | $57.59 | $58.32 | $57.59 | 372,230 | 05-22-2019 |
$ | $58.11 | $58.12 | $58.265 | $57.96 | 580,783 | 05-21-2019 |
$ | $57.75 | $57.93 | $58.38 | $57.32 | 385,318 | 05-20-2019 |
$ | $57.64 | $58.00 | $58.33 | $57.40 | 372,152 | 05-17-2019 |
$ | $58.10 | $57.78 | $58.36 | $57.75 | 809,349 | 05-16-2019 |
News, Short Squeeze, Breakout and More Instantly...
Bemis Company Inc. Company Name:
BMS Stock Symbol:
NYSE Market:
K36 Therapeutics Announces Presentation on KTX-1001 for Relapsed and Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting PR Newswire Poster to be presented Sunday, December 10, 2023 CAMBRIDGE, Mass. , Dec. 4, 2023 /PRNe...
Excellent dividend stocks are great to hold in times of economic downturns. Since the best of the best typically don't suspend -- or even reduce -- their dividend payments regardless of market and economic conditions, the regular and predictable dividend payments can help investors smooth o...
Exelixis (NASDAQ: EXEL) and bluebird bio (NASDAQ: BLUE) are two biotech companies that have been moving in opposite directions on the stock market this year. While Exelixis has provided healthy gains -- its stock is up by 52.1% year to date -- Bluebird's shares have slid by 35.2% since t...